Axogen, Inc. (AXGN): Price and Financial Metrics
AXGN Price/Volume Stats
| Current price | $14.69 | 52-week high | $14.88 |
| Prev. close | $14.29 | 52-week low | $3.45 |
| Day low | $14.29 | Volume | 779,400 |
| Day high | $14.88 | Avg. volume | 400,273 |
| 50-day MA | $10.85 | Dividend yield | N/A |
| 200-day MA | $8.54 | Market Cap | 642.03M |
AXGN Stock Price Chart Interactive Chart >
Axogen, Inc. (AXGN) Company Bio
AxoGen, Inc. operates as a medical technology company. It offers a portfolio of nerve repair solutions for various surgical peripheral nerve repair needs. The company is based in Alachua, Florida.
Latest AXGN News From Around the Web
Below are the latest news stories about AXOGEN INC that investors may wish to consider to help them evaluate AXGN as an investment opportunity.
Axogen, Inc. Appoints Kathy Weiler to its Board of DirectorsWeiler brings 20+ years of strategic and commercial leadership experience to the Axogen, Inc. Board of DirectorsALACHUA, Fla. and TAMPA, Fla., Dec. 26, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, is pleased to announce today the appointment of Mrs. Kathy Weiler to its Board of Directors, effective December 20, 2023. Weiler, a senior executive with 20+ years of experience and proven |
Axogen Announces Transition of Finance Team LeadershipNir Naor Appointed CFO to Replace Peter Mariani as Company Aligns Executive Team with Financial Management Needs for Next Phase of GrowthALACHUA, Fla. and TAMPA, Fla., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced the appointment of Mr. Nir Naor as Chief Financial Officer, effective immediately. A senior finance executive with more than 20 years of experience |
Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)ALACHUA and TAMPA, Fla., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced making Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) in connection with the employment and appointment of Harold D. Tamayo as Vice President of Finance and Investor Relations. Mr. Tamayo will report to Peter J. Mariani, Executive Vice President and Chief Financial Officer, and will |
Axogen, Inc. to Participate at the Piper Sandler 35th Annual Healthcare ConferenceALACHUA and TAMPA, Fla., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Karen Zaderej, Chairman, Chief Executive Officer, and President, will present at the Piper Sandler 35th Annual Healthcare Conference in New York, NY, on Thursday, November 30, 2023, at 8:50 a.m. E.T. Webcast events can be accessed live through the Investors page at www.axogeninc.com. F |
Great week for AxoGen, Inc. (NASDAQ:AXGN) institutional investors after losing 51% over the previous yearKey Insights Institutions' substantial holdings in AxoGen implies that they have significant influence over the... |
AXGN Price Returns
| 1-mo | 25.23% |
| 3-mo | N/A |
| 6-mo | 91.53% |
| 1-year | 173.56% |
| 3-year | -11.13% |
| 5-year | 3.31% |
| YTD | 115.08% |
| 2023 | -31.56% |
| 2022 | 6.51% |
| 2021 | -47.65% |
| 2020 | 0.06% |
| 2019 | -12.43% |
Continue Researching AXGN
Want to do more research on Axogen Inc's stock and its price? Try the links below:Axogen Inc (AXGN) Stock Price | Nasdaq
Axogen Inc (AXGN) Stock Quote, History and News - Yahoo Finance
Axogen Inc (AXGN) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...